Uncategorized
NINLAROTM (ixazomib) Receives Conditional Approval from the European Commission to Treat Multiple Myeloma
Takeda Pharmaceutical Company Limited announced that the European Commission has granted conditional marketing authorization for NINLAROTM （ixazomib） capsules, indicated in combination with lenalidomide and...
Press Releases
Pharma Parallel Trade: Beyond Brexit and EU Falsified Medicine Directive
Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices.With Brexit and...
Press Releases
Novo Nordisk receives US FDA approval for Xultophy 100/3.6
Novo Nordisk announced that the US FDA has approved the NDA for Xultophy® 100/3.6.Xultophy® 100/3.6 is indicated as an adjunct to diet and exercise...
Press Releases
MedImmune completes out-licensing agreement with Allergan for MEDI2070
AstraZeneca announced the completion of the licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc, for the global rights...
Press Releases
Largest Ever PACK EXPO Exceeds Highest of Expectations
On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the world’s largest and most comprehensive processing...
Press Releases
Shire launches CUVITRU™ [Immune Globulin Subcutaneous (Human), 20% Solution] in the U.S. for Primary Immunodeficiency
Shire plc announces the launch of CUVITRU , 20% Solution], the first and only Subcutaneous 20% treatment option without proline available in the U.S....
Industry Reports
Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs
Medivir AB announces that it has entered into an agreement to acquire two clinical stage oncology programs from Tetralogic Pharmaceuticals Corporation , advancing and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read